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Recent studies suggest that the effects of cognitive therapies for depression show systematic changes over time. A meta-analysis was conducted to explore the
temporal development of the effect of mindfulness-based cognitive therapy (MBCT) for current depression in studies that used the Beck Depression Inventory
(BDI) or the Hamilton Depression Rating Scale (HDRS) as outcome measures. A systematic search of research databases yielded 20 studies that were included
in the analyses. The results showed that MBCT is effective in reducing depressive symptoms. The effect sizes of studies using the BDI or the HDRS as an
outcome measure were not moderated by the time of publication. Funnel plots and the trim and fill method suggested that publication bias was low. However,
the number of available studies was small, and the time period investigated relatively short. The results should therefore be considered preliminary.
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INTRODUCTION
With an estimated global prevalence of 4.4% (WHO, 2017),
depression is one of the most common and frequently occurring
mental disorders, with a high rate of relapse and recurrence
(Steinert, Hofmann, Kruse, & Leichsenring, 2014). As such,
depression represents a significant burden on the individual and
society (Whiteford, Degenhardt, Rehm, Baxter, Ferrari, Erskine,
& Vos, 2013).
A variety of psychological therapies, including cognitive
therapy (CT), behavioral activation therapy, interpersonal therapy
and short-term psychodynamic therapy, have been shown to be
effective in the treatment of depression (Cuijpers, 2017).
Recently, mindfulness-based cognitive therapy (MBCT; Crane,
2009; Segal, Williams, & Teasdale, 2002; Segal, Williams,
Teasdale, & Kabat-Zinn, 2013) was developed as a modification
of CT to specifically prevent the relapse and recurrence of
depressive episodes in individuals who had recovered from
depression (Lau, 2016). MBCT is a manual-based treatment that
combines exercises in mindfulness training with cognitive
techniques. The integration of mindfulness practice with cognitive
interventions distinguishes MBCT from other mindfulness-based
interventions (MBIs), such as mindfulness-based stress reduction
(Kabat-Zinn, 1990). The overall goal of MBCT is to increase
metacognitive awareness (Lau, Segal, & Williams, 2004) and,
thereby, reduce cognitive and emotional reactivity (Gu, Strauss,
Bond, & Cavanagh, 2015).
Studies have shown that MBCT is effective in reducing the
relapse and recurrence of depression (Kuyken, Warren, Taylor,
Whalley, Crane, Bondolfi, & Schweizer, 2016; Piet & Hougaard,
2011). MBCT seems to be equally effective in reducing risk of
relapse as CBT (Farb, Anderson, Ravindran, Hawley, Irving,
Mancuso, & Segal, 2018) and more effective than antidepressant
medications in this regard (Kuyken et al., 2016). Although, in an
early paper, the developers of MBCT cautioned against using
MBCT to treat treating patients with acute depression (Teasdale,
Segal, Williams, Ridgeway, Soulsby, & Lau, 2000), MBCT has
subsequently been extended to this group. The treatment of
current unipolar depression with MBCT follows the original
manual by Segal et al. (2013) and is delivered in a group format
with up to 12 participants and one or two instructors. After an
individual pretreatment interview in which the participant’s
history of depression is discussed and information about MBCT is
provided, the treatment consists of eight weekly two-hour sessions
(Baer & Walsh, 2016).
Several meta-analyses have shown that mindfulness-based
interventions (MBIs) in general (e.g., Goldberg, Tucker, Greene,
Davidson, Wampold, Kearney, & Simpson, 2018; Goyal, Singh,
Sibinga, &, Singh, & Sibinga&&, 2014; Hedman-Lagerl€of,
Hedman-Lagerl€of, & €Ost, 2018; Hofmann, Sawyer, Witt, & Oh,
2010; Khoury, Lecomte, Fortin, Masse, Therien, Bouchard, &
Hofmann, 2013; McCarney, Schulz, & Grey, 2012; Strauss,
Cavanagh, Oliver, & Pettman, 2014; Wang, Li, Zheng, Xu, Ng,
Ungvari, & Xiang, 2018), and MBCT in particular (Galante,
Iribarren, & Pearce, 2013; Hofmann et al., 2010; Klainin-Yobas,
Cho, & Creedy, 2012; Lenz, Hall, & Bailey Smith, 2016), are
effective in reducing depressive symptoms. For example, a recent
meta-analysis of randomized controlled trials (RCTs) observed
effect sizes (ESs) of d = 0.59 for MBIs vs. no treatment and
d = 0.38 for MBIs vs. active control conditions (Goldberg et al.,
2018). For MBCT specifically, similar or higher ESs for the
reduction of depressive symptom severity have been reported. For
example, Hofmann et al. (2010) observed an average ES of 0.85
(Hedges’s g) in nine pre-post studies. Lenz et al. (2016) reported
mean ES of g = 0.76 and 0.54 for MBCT vs. waitlist or no
treatment and for MBCT vs. alternative treatments, respectively,
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in RCTs. Recently. Goldberg, Tucker, Greene, Davidson,
Kearney, and Simpson (2019) found that MBCT was superior to
non-specific control conditions (d = 0.71) at posttest but not more
effective than other active treatments (d = 0.00).
In previous meta-analyses of MBCT for acute depression, the
temporal development of ESs in treatment studies has received little
attention. This may not be surprising, as MBCT is a relatively new
development. However, the investigation of the relationship
between time of study and ES is important, as it informs about time
trends and developments that can be positive or negative and call
for action. For example, a decline in ESs for individual CBT for
depression has been observed in published studies over time using a
version of the Beck Depression Inventory (BDI; Beck, Steer, &
Brown, 1996; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961)
and/or the Hamilton Depression Rating Scale (HDRS; Hamilton,
1960) as outcome measures (Cristea, Stefan, Karyotaki, David,
Hollon, & Cuijpers, 2017; Johnsen & Friborg, 2015). Several
possible explanations for these findings have been discussed,
including more heterogeneous and complex samples in more recent
trials, therapist training, and lack of adherence to the treatment
manual (Dobson, 2016; Johnsen & Friborg, 2015; Waltman, Creed,
& Beck, 2016). In contrast, an increase in ESs for group CBT for
depression was observed when the BDI was used as outcome
measure but was not observed when the HDRS was used (Johnsen
& Thimm, 2018). As MBCT is an anti-depressive treatment that
shares key concepts and features with traditional CBT and usually
is delivered in a group format, the investigation of the time-trends
connected to this treatment form can give new and relevant insights.
For example, combined with the previous research on the temporal
development of ESs in studies of individual CBT and group CBT,
analyses such as the present one can provide indications as to
whether any time-trends can be connected to the treatment format
(group vs. individual therapy), or, alternatively, can be related to the
focus of the interventions rather than the treatment format.
Thus, the aim of the present exploratory study is to examine
the effect of MBCT on the treatment of current depression and
the development of ESs over time. Since the BDI and the HDRS
are the most widely used instruments for evaluating the
effectiveness of cognitive therapies for depression (Johnsen &
Friborg, 2015), the analysis will focus on studies that used the
BDI and/or the HDRS as outcome measures to allow for time
trends of depression treatment to be compared with previous
studies. In the analysis, studies comparing MBCT to control
condition with and without active treatments and studies
examining pre-post differences were included. Recently, it has
been suggested that ESs based on within-group scores should be
avoided in meta-analysis if possible (Cuijpers, Weitz, Cristea, &
Twisk, 2017). While there is no doubt that between-group RCTs
is the gold standard when it comes to conduct meta-analysis, there
are also several salient reasons why the inclusion of within-group
based ESs could be helpful - albeit used with caution when it
comes to interpretation of the results. First, the scope of papers
could be greatly expanded, which would increase the statistical
power. Second, we believe that meta-analyses on time-trends are
not as vulnerable to some of the pitfalls as meta-analyses
measuring standard treatment effects. For example, one common
objection to within-group pre-post standardized mean differences
is that they are influenced by natural processes and characteristics
of patients and settings, which cannot be discerned from the
effects of the intervention. However, when it comes to research of
temporal developments in treatment efficacy related to any
particular treatment form, variations in the characteristics of
patients and settings (as well as general environment and society)
could very well be highly relevant moderators to consider when it
comes to interpreting the reasons behind any temporal
development of treatment effects. Identification of any
characteristics or processes that change systematically with the
passing of time, influencing treatment effects, are of major
importance. Finally, the most accurate indicator of reliability for
any pre-post ES-calculation is heterogeneity. If this index is at a
satisfactorily level, within-group ES’s could be an informative
calculation of ESs. With these considerations in mind, we have
for the present study chosen to perform a primary analysis
utilizing between-group RCT-based ESs, and a secondary analysis
utilizing within-group ESs. We expect that the outcomes of the
two calculations regarding the temporal development of ESs
would be similar and thus validate each other’s results.
METHODS
To identify relevant studies, a systematic search was conducted in research
databases MEDLINE, PsychINFO and EMBASE on January 20, 2018.
The broad search query “mindfulness AND depress*” was used to
minimize the risk of missing relevant studies. In addition, previous
systematic reviews and published meta-analyses of MBIs for mental
disorders were manually searched. After removal of duplicates, in the first
stage of the study selection, the titles, abstracts, types of references, and
language of publication were screened by the first author. In the second
round, both authors assessed the full text of studies for eligibility. The
following inclusion criteria were applied: 1) MBCT was given in a group
format aimed at reducing depression; 2) participants were adults
(≥18 years of age) diagnosed with depression or showing elevated scores
on the BDI (> 13) or the HDRS (> 8), as a group; 3) a version of the BDI
or the HDRS was used as an outcome measure; and 4) publication was in
English and was in a peer-reviewed journal. Studies were excluded when
1) MBIs other than MBCT were examined, 2) no treatment effects for
MBCT were investigated or reported, 3) depression was not the principal
problem of the participants; 4) partial or complete sample overlap with a
study already included in the meta-analysis was observed, 5) information
necessary to calculate ES (i.e., means and standard deviations) was
lacking, or 6) only dichotomous outcomes (e.g., relapse) were reported.
For each study included in the meta-analysis, the following information
was extracted: 1) year of publication; 2) sample size of the MBCT group
and the control group; 3) mean age and percentage of females in the
MBCT group; 4) number of sessions; 5) modification of the treatment
manual by Segal et al. (2002) or Segal et al. (2013); 6) use of the BDI or
BDI-II as outcome measure; 7) no treatment vs. active treatment
comparison groups; 8) randomization of participants; and 9) reporting
results of intent-to-treat (ITT) analyses.
For the meta-analytic calculations, means and standard deviations of the
BDI and/or the HDRS at pre-treatment and post-treatment were extracted
for the treatment group and, if present, for the control group(s).
To assess the methodological quality of the studies included in the meta-
analysis, the Jadad scale (Jadad, Moore, Carroll, Jenkinson, Reynolds,
Gavaghan, & McQuay, 1996) was used. Both authors assessed the studies
independently. Rater agreement was calculated using double entry
intraclass correlation (McCrae, 2008). The coefficient for study quality was
.91. Discrepant ratings were clarified and resolved through discussion.
To obtain the ES for each study, the standardized mean difference
(SMD) between the intervention group and control group, and/or the
pretest and the posttest was calculated correcting for bias (Hedges’ g).
Following the recommendations by Rosenthal (1993), a conservative pre-
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post correlation of .7 was set. The mean ES across studies was calculated
using a random effects model. The analyses were conducted separately for
controlled studies (between-group) with and without active treatment
comparisons and pre-post differences (within-group) and for the BDI/BDI-
II and HDRS as outcome measures. When data for ITT samples were
available, these were preferred over data from completer samples.
To examine publication year as moderator for the pooled ES, meta-
regression analysis was used.
Heterogeneity among studies was assessed using Q tests and the I2
statistic (Higgins, Thompson, Deeks, & Altman, 2003), which is a
measure of the proportion of the total variance across studies that is due to
heterogeneity. Higgins et al. (2003) suggest that I2 values of 25% indicate
low heterogeneity, 50% indicate moderate heterogeneity, and 75% indicate
high heterogeneity between studies.
To assess publication bias, funnel plots were obtained, and Duval and
Tweedie’s (2000) trim and fill method was used to estimate the number of
missing studies and the ESs after imputation of the missing studies.
All analyses were conducted in Comprehensive Meta-Analysis version
3 (CMA; Borenstein, Hedges, Higgins, & Rothstein, 2017).
RESULTS
Study selection
After duplicates were removed, the search resulted in 4,010
unique studies. In the screening process, 3869 studies were
excluded. One hundred forty-one full-text articles were retrieved,
121 of which were excluded based on the eligibility criteria.
Thus, 20 eligible studies were retained for the meta-analysis (see
Figure 1 for the flowchart of the selection process).
Study characteristics
The study characteristics are displayed in Table 1. The included
studies were published between 2007 (Kenny & Williams, 2007;
Kingston, Dooley, Bates, Lawlor, & Malone, 2007 and 2017
(Greenberg, Shapero, Mischoulon, & Lazar, 2017). The average
number of participants in the MBCT condition was 41.2 (SD = 46.2,
range 6 to 212). The total number of participants was 824. In ten
studies, the original MBCT manual was modified to adapt the
treatment to the target group. Eighteen studies were RCTs (14) or
included a control condition without randomization (4). Seven of
these 18 studies included an active control condition (antidepressant
medication in three studies, and psychological treatment in four
studies). Two studies had two control groups (Hosseinian,
Shahtaheri, Ebrahimi, Mahdavi, & Sepahvandi, 2016; Michalak,
Schultze, Heidenreich, & Schramm, 2015). Two studies used a pre-
post design. Treatment outcome was measured with a version of the
BDI in 15 between-group studies and two within-group studies and
with the HDRS in nine between-group studies. As to study quality,
the average Jadad score was 1.90 (SD = 1.17, range 0–3).
Effects of MBCT on current depression and analysis of time
trends
The average weighted ES for between-group studies using a no-
treatment control group and the BDI as an outcome measure
(n = 11) was g = 0.92 (95% CI [0.70, 1.14]; Q(10) = 17.45,
p = 0.065, I2 = 42.7). The trim and fill method suggested that
two studies were missing, and the imputed point estimate was
g = 0.86 (95% CI [0.63, 1.08]). When an active treatment
comparison group was included (n = 5), the ES for the BDI was
g = 0.45 (95% CI [0.09, 0.80];Q(4) = 11.16, p = 0.025,
I2 = 64.2). The trim and fill method suggested that no studies
were missing. For the between-group studies using the HDRS and
a no-treatment control group (n = 7), the ES was g = 0.80 (95%
CI [0.61, 0.99]; Q(6) = 7.15, p = 0.308, I2 = 16.04). The trim
and fill method suggested that two studies were missing, and the
imputed point estimate was g = 0.72 (95% CI [0.51, 0.92]). For
studies using an active treatment control group and the HDRS
(n = 4), the mean weighted ES was g = 0.37 (95% CI [0.21,
0.54]; Q(3) = 2.62, p = 0.454, I2 = 0). The trim and fill method
suggested that one study was missing, and the imputed point
estimate was g = 0.34 (95% CI [0.12, 0.56]).
With respect to pre-post differences on the BDI, studies using a
within-group design were pooled with between-group studies
(n = 17), resulting in an ES of g = 0.90 (95% CI [0.70, 1.09]; Q
(16) = 120.36, p < .001, I2 = 86.7). The trim and fill method
suggested that no studies were missing. The ES of the
Abolghasemi, Gholami, Narimani, and Gamji (2015) study was
considerably larger than the ESs of the other studies (g = 5.18,
95% CI [3.70, 6.70]). When the Abolghasemi et al. (2015) study
was removed from the analysis, the average weighted ES was
g = 0.82 (95% CI [0.66, 0.99], Q(15) = 84.27, p < .001,
I2 = 82.2). There were no within-group studies that used the
HDRS as an outcome measure. ESs for the individual studies are
presented in Figures 2 through 6.
Visual inspections of the funnel plots revealed largely
symmetrical distributions. The funnel plots of the observed and
imputed studies are provided in the supplemental material Figures
S1 to S5.
Analysis of time trends showed no significant relationships
between year of publication and ES for between-group studies
with the BDI as an outcome measure and with no-treatment
comparisons (b = 0.03, 95% CI [0.11, 0.05], p = 0.440),
active treatment comparisons (b = 0.02, 95% CI [0.28, 0.24],
p = 0.863), and in pre-post designs (b = 0.01, 95% CI [0.07,
0.05], p = 0.657, and b = 0.03, 95% CI [0.08, 0.01],
p = 0.155 when the Abolghasemi et al. (2015) study was
excluded). For studies using the HDRS, the associations between
year of publication and ES were not significant for between-group
comparisons with no treatment (b = 0.04, 95% CI [0.13,
0.05], p = 0.348) and active treatment comparisons (b = 0.10,
95% CI [0.95, 0.74], p = 0.810).
Analysis of other moderators
In addition to year of publication, sample size, average age,
gender distribution, and baseline level of depression in the MBCT
group, as well as study quality (Jadad score), were examined as
moderators. None of these variables moderated the ESs of
between-group studies with no-treatment controls using the BDI
(sample size: b = 0.00, 95% CI [0.01, 0.00], p = 0.389; age:
b = 0.01, 95% CI [0.07, 0.05], p = 0.758; gender:
b = 0.01, 95% CI [0.03, 0.02], p = 0.677; baseline
depression: b = 0.02, 95% CI [0.02, 0.06], p = 0.262; study
quality: b = 0.07, 95% CI [0.28, 0.15], p = 0.546) or the
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HDRS (sample size: b = 0.00, 95% CI [0.01, 0.01], p = 0.624;
age (b = 0.04, 95% CI [0.12, 0.04], p = 0.313; gender:
b = 0.02, 95% CI [0.00, 0.03], p = 0.087; baseline depression:
b = 0.02, 95% CI [0.05, 0.01], p = 0.271; study quality:
b = 0.07, 95% CI [0.48, 0.33], p = 0.727). No moderation of
these variables was also found for studies with active treatment
comparisons using the BDI (sample size: b = 0.00, 95% CI
[0.01, 0.01], p = 0.835; age: b = 0.01, 95% CI [0.04, 0.03],
p = 0.752; gender: b = 0.02, 95% CI [0.01, 0.05], p = 0.252;
baseline depression: b = 0.00, 95% CI [0.06, 0.06], p = 0.908;
study quality: b = 0.30, 95% CI [0.78, 0.17], p = .208) and
the HDRS (sample size: b = 0.00, 95% CI [0.00, 0.00],
p = 0.183; age: not enough studies; gender: b = 0.01, 95% CI
[0.03, 0.01], p = 0.462; baseline depression: b = 0.01, 95% CI
[0.01, 0.04], p = 0.177; study quality: b = 0.03, 95% CI
[0.31, 0.25], p = 0.854).
For within-group comparisons using the BDI, sample size
(b = 0.00, 95% CI [0.01, 0.00], p = 0.013), age (b = 0.08,
95% CI [0.12, 0.03], p < 0.001), and baseline depression
(b = 0.04, 95% CI [0.01, 0.06], p = 0.002) were significant
moderators, but sex (b = 0.01, 95% CI [0.03, 0.01],
p = 0.353) and study quality (b = 0.14, 95% CI [0.29, 0.01],
p = 0.078) were not. When the Abolghasemi et al. (2015) study
was excluded from the analyses, sample size (b = 0.00, 95% CI
[0.01, 0.00], p = 0.002) and baseline depression (b = 0.03, 95%
CI [0.00, 0.05], p = 0.020) were significant moderators but not
age (b = 0.03, 95% CI [0.07, 0.01], p = 0.110), sex
(b = 0.00, 95% CI [0.02, 0.02], p = 0.976), and study quality
(b = 0.10, 95% CI [0.24, 0.05], p = 0.202). Thus, smaller
sample size and higher baseline depression was associated with
higher ESs across statistical conditions.
DISCUSSION
The present meta-analysis explored the development of ESs for
MBCT over time in the treatment of current depression in studies
that used the BDI or the HDRS as outcome measures. Previous
findings indicated significant changes in the ESs of individual and
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MEDLINE (n = 1,225)
EMBASE (n = 2,306)
Additional records identified 
through other sources
(n = 49)












Full-text articles excluded 
(n = 121):
- no current depression (18)
- outcome measure not 
BDI/HDRS (35)
- depression not principal 
problem (16)
- sample overlap with 
included study (15)
- depression not target of 
treatment (29)
- lack of data (6)
- not group MBCT (2)
Fig. 1. Flowchart of the search and selection procedure.
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group CBT for depression over time (Cristea et al., 2017; Johnsen
& Friborg, 2015; Johnsen & Thimm, 2018). The main goal of the
present study was, therefore, to examine if reported time trends of
ESs for MBCT for depression could be observed in the different
studies.
The results showed that the ESs of studies using between- and
within-group designs and the BDI or the HDRS as an outcome
measure were not moderated by the time of publication. In
previous studies of time trends of ESs, diverging results for the
BDI and HDRS have been observed (e.g., Johnsen & Thimm,
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2018) and have been related to the different ways of
administration of the two instruments: the BDI is a self-report
inventory, while the HDRS is rated by a clinician. In addition, the
BDI assesses cognitive symptoms of depression to a higher
degree than does the HDRS, which focuses more on somatic
symptoms (cf. Wampold & Imel, 2015). Thus, while a decline in
ESs for individual CBT for depression and an increase in ESs for
group CBT have been observed (Cristea et al., 2017; Johnsen &
Friborg, 2015; Johnsen & Thimm, 2018), no effects of time for
the ESs of MBCT were found. Neither were there any indications
of potential trends towards a decline or increase in ES, as the
regression line was nearly neutral (flat) for all statistical
conditions. A probable reason for this finding is that studies of
MBCT for depression have used heterogeneous samples from the
beginning, i.e., included participants with various conditions in
addition to depression and had no strict exclusion criteria (cf.
Dobson, 2016). On the other hand, an improvement in ESs over
time was not observed either. It can only be speculated whether
the reported ESs of MBCT for current depression already
represent the upper limit of its effectiveness or whether factors
such as insufficient therapist training and supervision (cf.
Waltman et al., 2016) inhibit an increase of the effects.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Barnhofer et al. (2009) 1,033 0,374 0,140 0,301 1,766 2,765 0,006
Chiesa et al. (2015) 0,662 0,308 0,095 0,057 1,266 2,145 0,032
Crane et al. (2008) 0,859 0,318 0,101 0,236 1,483 2,700 0,007
De Raedt et al. (2012) 0,786 0,253 0,064 0,289 1,283 3,101 0,002
Godfrin & van Heeringen (2010) 1,367 0,215 0,046 0,946 1,787 6,371 0,000
Greenberg et al. (2017) 1,787 0,462 0,214 0,881 2,693 3,865 0,000
Kingston et al. (2007) 1,464 0,543 0,295 0,400 2,529 2,695 0,007
Mann et al. (2016) 0,317 0,320 0,102 -0,310 0,944 0,992 0,321
Michalak et al. (2015) 0,883 0,246 0,061 0,400 1,365 3,586 0,000
Van Alderen et al. (2012) 0,647 0,143 0,020 0,367 0,926 4,528 0,000
Verhoeven et al. (2014) 1,125 0,289 0,084 0,558 1,692 3,887 0,000
0,923 0,113 0,013 0,702 1,144 8,183 0,000
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 2. Forest plot for between-group studies using the BDI and no-treatment control groups.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Abolghasemi et al. (2015) 0,512 0,361 0,131 -0,197 1,220 1,416 0,157
Hamidian et al. (2013) 1,344 0,329 0,108 0,699 1,988 4,085 0,000
Kuyken et al. (2015) 0,397 0,098 0,010 0,205 0,589 4,055 0,000
Manicavasgar et al. (2011) 0,123 0,297 0,088 -0,459 0,705 0,414 0,679
Michalak et al. (2015) 0,071 0,235 0,055 -0,389 0,532 0,304 0,761
0,446 0,180 0,032 0,093 0,799 2,474 0,013
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 3. Forest plot for between-group studies using the BDI and active treatment control groups.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Chiesa et al. (2015) 1,004 0,319 0,102 0,378 1,629 3,146 0,002
Geschwind et al. (2011) 0,840 0,183 0,033 0,481 1,198 4,595 0,000
Godfrin & van Heeringen (2010) 1,116 0,208 0,043 0,709 1,522 5,375 0,000
Greenberg et al. (2017) 1,037 0,429 0,184 0,197 1,878 2,419 0,016
Hosseinian et al. (2016) 0,854 0,413 0,171 0,044 1,663 2,067 0,039
Michalak et al. (2015) 0,362 0,237 0,056 -0,102 0,826 1,528 0,126
van Alderen et al. (2012) 0,685 0,143 0,021 0,405 0,966 4,785 0,000
0,798 0,096 0,009 0,610 0,987 8,320 0,000
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 4. Forest plot for between-group studies using the HDRS and no-treatment control groups.
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As to the overall effect of MBCT for acute depression, the
results of the present study are consistent with previous meta-
analytic studies (e.g., Goldberg et al., in press; Lenz et al., 2016),
suggesting that MBCT is effective in reducing symptoms of
depression. Applying Cohen’s (1992) criteria, the average ESs for
between-group studies comparing MBCT to no-treatment control
conditions and pre-post studies were large for both outcome
measures. Studies with active control conditions showed moderate
average ESs in favor of MBCT. The trim and fill method
indicated that publication bias was present for three of the five
meta-analytic conditions. However, the estimated number of
missing studies did not exceed two, suggesting that overall
publication bias is low. Consistent with previous findings (e.g.,
K€uhberger, Fritz, & Scherndl, 2014), there was a negative
association between sample size and ES in within-group studies,
i.e., studies with smaller samples tended to show higher ES than
studies with larger samples. Similarly, higher baseline levels of
depression were related to higher ESs. Based on the robust
finding of the effectiveness of MBCT for current depression, it
has been proposed that MBCT should be offered as a first-line
treatment for depression on equal terms with other evidence-based
treatments (Strauss et al., 2014). However, more research is
needed to support this claim. It should be noted that the average
ES observed for MBCT when compared to no treatment
comparisons is lower than those for other psychological
treatments. For example, for individual and group CBT, average
ESs of g = 1.37 and g = 1.14, respectively, have been reported
for between-group studies using the BDI (Johnsen & Friborg,
2015;Johnsen & Thimm, 2018). The corresponding ES for MBCT
in the current study was g = 0.92. Additionally, for pre-post
comparisons, the average ES for MBCT observed in the present
study (g = 0.90, g = 0.82 when the Abolghasemi et al. (2015)
study was excluded) is smaller than those for individual and
group CBT in clinical trials (g = 1.65 and g = 1.33, respectively;
Johnsen & Friborg, 2015; Johnsen & Thimm, 2018) and in
routine clinical practice (d = 1.06; Hans & Hiller, 2013).
When interpreting the results of the present investigation,
several limitations have to be considered. Compared to previous
examinations of temporal development of the effects of CBT for
depression, the period in which the studies investigating the
effects of MBCT for depression were conducted was relatively
short. Further, the number of available studies was small.
Chronicity of depression and an assessment of adherence to the
MBCT manual was not reported in most publications and could,
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Eisendraht et al. (2015) 0,537 0,306 0,093 -0,062 1,136 1,758 0,079
Hosseinian et al. (2016) 0,314 0,397 0,157 -0,464 1,092 0,792 0,429
Kuyken et al. (2015) 0,304 0,098 0,010 0,113 0,495 3,120 0,002
Michalak et al. (2015) 0,699 0,242 0,059 0,224 1,173 2,887 0,004
0,371 0,085 0,007 0,205 0,537 4,378 0,000
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 5. Forest plot for between-group studies using the HDRS and active treatment control groups.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Abolghasemi et al. (2015) 5.182 0.757 0.573 3.699 6.665 6.847 0.000
Barnhofer et al. (2009) 1.070 0.235 0.055 0.609 1.531 4.553 0.000
Chiesa et al. (2015) 0.658 0.173 0.030 0.319 0.997 3.802 0.000
Crane et al. (2008) 0.578 0.185 0.034 0.215 0.941 3.124 0.002
De Raedt et al. (2012) 0.612 0.125 0.016 0.366 0.858 4.883 0.000
Eisendraht et al. (2008) 0.953 0.125 0.016 0.708 1.197 7.638 0.000
Godfrin & van Heeringen (2010) 0.993 0.130 0.017 0.739 1.248 7.643 0.000
Greenberg et al. (2017) 1.431 0.307 0.094 0.829 2.034 4.656 0.000
Hamidian et al. (2013) 1.206 0.213 0.045 0.790 1.623 5.675 0.000
Kenny & Williams (2007) 1.049 0.141 0.020 0.773 1.324 7.456 0.000
Kingston et al. (2007) 1.679 0.460 0.212 0.777 2.581 3.648 0.000
Kuyken et al. (2015) 0.338 0.055 0.003 0.231 0.445 6.195 0.000
Manicavasgar et al. (2011) 0.840 0.200 0.040 0.448 1.233 4.195 0.000
Mann et al. (2016) 0.488 0.181 0.033 0.134 0.843 2.699 0.007
Michalak et al. (2015) 0.750 0.144 0.021 0.468 1.031 5.218 0.000
Van Alderen et al. (2012) 0.527 0.081 0.007 0.368 0.686 6.482 0.000
Verhoeven et al. (2014) 1.035 0.178 0.032 0.686 1.384 5.811 0.000
0.898 0.100 0.010 0.703 1.093 9.017 0.000
-1.00 -0.50 0.00 0.50 1.00
Favors A Favors B
Fig. 6. Forest plot for within-group studies using the BDI.
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therefore, not be included in the analyses. Particular caution is
warranted when interpreting the results from within-studies due to
data dependence (Cuijpers et al., 2017). Heterogeneity was found
to be significant for two of the analyses (between-group studies
using an active treatment control group and the BDI and pre-post
differences on the BDI). The I2 index further indicated that
heterogeneity was low for the two analytical conditions based on
the HDRS (I2 = 0, and I2 = 16.04, respectively), while two of the
conditions based on the BDI showed moderate ranges (I2 = 42.7
and I2 = 64.2, respectively). These values are highly acceptable,
especially when taking into consideration that meta-analyses in
the field of psychology are notorious for having large degrees of
heterogeneity, as proven in a recent study examining rates of I2 in
61 published meta-analyses in Psychological Bulletin between
1990 and 2013 (van Erp, Verhagen, Grasman, & Wagenmakers,
2017). The authors found that over half of the between-study
meta-analyses showed I2> 70. For the final analysis in the present
study, I2 = 86.7 was found for the within–group condition. This
is not uncommon, as higher degrees of heterogeneity are
associated with within-group analyses. The finding may be due to
the less rigid (and less precise) statistical requirements, as no
control groups are implemented in the analysis, thus inherently
leaving room for larger variability between the included studies.
In addition, the high heterogeneity might be due to differences
between studies in the efficacy of MBCT. Future studies should
examine possible additional moderators, e.g., variables related to
the implementation of the treatment. Finally, the present meta-
analysis was restricted to studies that used a version of the BDI or
HDRS as outcome measures. Including studies that used other
instruments could lead to different findings.
In conclusion, the results of the present meta-analysis show that
MBCT is effective in reducing symptoms of current depression
and that study findings are stable over time. However, the
relatively small number and short time range of the studies
included in the analysis require further investigations in the
future.
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